Characteristic

N = 127

Age, years, median (range)

73 (48-89)

Sex, male, n (%)

61 (48%)

Diabetes millitus, n (%)

60 (48%)

Alcohol, n (%)

46 (37%)

CEA, ng/ml, median (range)

3.5 (0.5-39)

CA19-9, U/ml, median (range)

53 (1-11153)

Operative procedures

Pancreaticoduodenectomy

64 (50%)

Distal pancreatectomy

60 (47%)

Total pancreatectomy

3 (2.4%)

Stage, n%

0

1 (0.7%)

IA

18 (14%)

IB

5 (4%)

IIA

43 (34%)

IIB

58 (46%)

III

1 (0.7%)

IV

1 (0.7%)

Maximum tumor size, mm, median (range)

24 (4-110)

Histologial type

Well differentiated type, n (%)

49 (39%)

Moderately differentiated type, n (%)

56 (44%)

Poorly differentiated type, n (%)

11 (8.7%)

Scirrhous type, n (%)

0

Staging

fCH (+), n (%)

35 (28%)

fDU (+), n (%)

35 (28%)

fS (+), n (%)

44 (35%)

fRP (+), n (%)

74 (58%)

fPV (+), n(%)

23 (18%)

fA (+), n(%)

10 (8%)

Lymph node metastasis (+), n (%)

57 (45%)

Adjuvant chemotherapy, n (%)

72 (57%)

GEM, n (%)

25 (20%)

GEM + S-1, n (%)

1 (0.8%)

nabPTX + GEM, n(%)

1 (0.8%)

S-1, n (%)

45 (35%)